Improving diabetes management for newly diagnosed children with type 1 diabetes
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
This study is testing a new program called 4T to help kids recently diagnosed with type 1 diabetes manage their blood sugar better and feel good emotionally, using the latest technology and personalized support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10771231 on NIH RePORTER |
What this research studies
This research focuses on implementing a comprehensive program called 4T, which stands for Teamwork, Targets, Technology, and Tight Control, to help newly diagnosed pediatric patients with type 1 diabetes (T1D). The program aims to maintain tight glucose control and enhance psychosocial outcomes by utilizing advanced diabetes technology and education strategies. Participants will receive personalized management recommendations based on their glucose data and psychosocial assessments, with the goal of reducing HbA1c levels and improving overall well-being. The study will compare outcomes with historical data to evaluate its effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are children recently diagnosed with type 1 diabetes who are seeking improved management strategies.
Not a fit: Patients who have been living with type 1 diabetes for an extended period may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better glucose control and improved quality of life for children newly diagnosed with type 1 diabetes.
How similar studies have performed: Previous research has shown success in implementing similar diabetes management programs, indicating potential for positive outcomes in this approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Maahs, David Matthew — Stanford University
- Study coordinator: Maahs, David Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.